


Healthcare Industry News: HIV/AIDS
News Release - December 15, 2006
96-Week Data From Gilead's Study 934 Comparing Viread(R) and Emtriva(R) to Combivir(R) Both in Combination With Sustiva(R) Published in Journal of Acquired Immune Deficiency Syndrome
Source: Gilead Sciences
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
